The content on this site is intended for healthcare professionals only
Simon Hollingsworth speaks to ecancer at EAPM 2017 in Belfast.
He discusses the process involved to develop drugs.
He highlights some of the challenges with personalised medicine and clinical trials.
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Genomic testing: Awareness and effective communication between healthcare professionals and patients
OncoAlert Round Up for September 15-21, 2023
Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
CodeBreaK 200 shows sotorasib to be a more tolerable treatment option for patients with pretreated, KRASG12C-mutated advanced NSCLC
SOFT study: Clinical relevance of genomic alterations in premenopausal HR+, HER2- early breast cancer
